Global life sciences risk report 2024 : How the industry perceives emerging risks and challenges
<?xml version="1.0" encoding="UTF-8"?><modsCollection xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-8.xsd">
<mods version="3.8">
<titleInfo>
<title>Global life sciences risk report 2024</title>
<subTitle>: How the industry perceives emerging risks and challenges</subTitle>
</titleInfo>
<name type="corporate" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20170016144">
<namePart>Willis Towers Watson</namePart>
<nameIdentifier>MAPA20170016144</nameIdentifier>
</name>
<typeOfResource>text</typeOfResource>
<originInfo>
<place>
<placeTerm type="code" authority="marccountry">gbr</placeTerm>
</place>
<issuance>monographic</issuance>
<place>
<placeTerm type="text">London</placeTerm>
</place>
<publisher>Willis Towers Watson</publisher>
<dateIssued>2024</dateIssued>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<form authority="marcform">print</form>
<extent>24 p.</extent>
</physicalDescription>
<abstract displayLabel="Summary">The life science sector has experienced rapid evolution in recent years, driven by scientific breakthroughs in areas such as gene and cell therapies, biologics and new vaccines. However, this swift progress has also brought challenges. Some innovations have not lived up to their initial promise, and concerns about the high costs of drug development have grown. Additionally, companies are struggling to find individuals with the specialized skills they need. In our second Life Science global survey, we asked 400 senior decision-makers about their perspectives on this changing landscape. We explored their views on the main risks and opportunities, how they are managing emerging challenges, and their plans for the future</abstract>
<note>Internacional</note>
<subject xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20100037607">
<topic>Ciencias de la salud</topic>
</subject>
<subject xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20080591182">
<topic>Gerencia de riesgos</topic>
</subject>
<subject xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20100017982">
<topic>Riesgos emergentes</topic>
</subject>
<subject xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20170006503">
<topic>Transformación digital</topic>
</subject>
<subject xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20080606787">
<topic>Innovación empresarial</topic>
</subject>
<subject xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20120019492">
<topic>Tendencias</topic>
</subject>
<subject xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20080585266">
<topic>Factores de riesgo</topic>
</subject>
<subject xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20080550592">
<topic>Encuestas</topic>
</subject>
<classification authority="">7</classification>
<location>
<url displayLabel="electronic resource" usage="primary display">https://www.wtwco.com/en-us/insights/2024/06/global-life-science-risk-report-2024</url>
</location>
<relatedItem>
<titleInfo>
<title>Global life sciences risk outlook 2023. Managing emerging risks, challenges and opportunities in the life science sector : WTW global life science survey</title>
</titleInfo>
<originInfo>
<publisher>London : Willis Towers Watson, 2022</publisher>
</originInfo>
<identifier type="local">MAP20230004678</identifier>
</relatedItem>
<recordInfo>
<recordContentSource authority="marcorg">MAP</recordContentSource>
<recordCreationDate encoding="marc">230315</recordCreationDate>
<recordChangeDate encoding="iso8601">20240704121200.0</recordChangeDate>
<recordIdentifier source="MAP">MAP20240010898</recordIdentifier>
<languageOfCataloging>
<languageTerm type="code" authority="iso639-2b">spa</languageTerm>
</languageOfCataloging>
</recordInfo>
</mods>
</modsCollection>